Transient tritanopia in migraine: Evidence for a large-field retinal abnormality in blue-yellow opponent pathways

Investigative Ophthalmology and Visual Science

Volumn 47, Issue 11, 2006, Pages 5125-5131

  Tibber, Marc S ^a   Shepherd, Alex J ^a  

^a UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTATION; ADULT; ARTICLE; CLINICAL ARTICLE; COLOR; COLOR DISCRIMINATION; COLOR VISION; CONTROLLED STUDY; CORRELATION ANALYSIS; DECISION MAKING; FEMALE; HUMAN; MALE; PATTERN RECOGNITION; PRIORITY JOURNAL; REINFORCEMENT; RETINA CONE; RETINA DISEASE; RISK ASSESSMENT; SPECTRAL SENSITIVITY; TRANSIENT TRITANOPIA; VISUAL STIMULATION; VISUAL THRESHOLD; COLOR VISION DEFECT; COLOR VISION TEST; MIGRAINE; PATHOPHYSIOLOGY; PERCEPTIVE THRESHOLD; QUESTIONNAIRE; VISUAL FIELD; VISUAL SYSTEM;

ADULT; COLOR PERCEPTION; COLOR PERCEPTION TESTS; COLOR VISION DEFECTS; CONES (RETINA); FEMALE; HUMANS; MALE; MIGRAINE DISORDERS; QUESTIONNAIRES; SENSORY THRESHOLDS; VISUAL FIELDS; VISUAL PATHWAYS;

EID: 34247111850     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.06-0393     Document Type: Article

References (68)

1. Airy H. On a distinct form of transient hemiopsia. Philos Trans R Soc Lond. 1870;160:247-264.
2. Wilkins A, Nimmo-Smith I, Tait A, McManus C, Della Sala S, Tilley A, et al. A neurological basis for visual discomfort. Brain. 1984;107:989-1017.
3. Shepherd AJ. Visual contrast processing in migraine. Cephalalgia. 2000;20:865-880.
4. Mulleners WM, Aurora SK, Chronicle E, Stewart R, Gopal S, Koehler PJ. Self-reported photophobic symptoms in migraineurs and controls are reliable and predict diagnostic category accurately. Headache. 2000;41:31-39.
5. Olesen J, Tfelt-Hansen P, Welch KMA. The Headaches. Philadelphia: Lippincott Williams & Wilkins; 2000.
6. Chronicle EP, Mulleners WM. Visual system dysfunction in migraine: a review of clinical and psychophysical findings. Cephalalgia. 1996;16:525-535.
7. Ambrosini A, de Noordhout AM, Sandor PS, Schoenen J. Electrophysiological studies in migraine: a comprehensive review of their interest and limitations. Cephalalgia. 2003;23(suppl 1):13-31.
8. Schoenen J, Ambrosini A, Sandor PS, Maertens de Noordhout A. Evoked potentials and transcranial magnetic stimulation in migraine: published data and viewpoint on their pathophysiologic significance. Clin Neurophysiol. 2003;114:955-972.
9. Shepherd A. Local and global motion after-effects are both enhanced in migraine, and the underlying mechanisms differ across cortical areas. Brain. 2006;129:1833-1843.
10. Coleston DM, Chronicle E, Ruddock KH, Kennard C. Precortical dysfunction of spatial and temporal visual processing in migraine. J Neurol Neurosurg Psychiatry. 1994;57:1208-1211.
11. Oelkers R, Grosser K, Lang E, et al. Visual evoked potentials in migraine patients: alterations depend on pattern spatial frequency. Brain. 1999;122:1147-1155.
12. McKendrick AM, Vingrys AJ, Badcock DR, Heywood JT. Visual dysfunction between migraine events. Invest Ophthalmol Vis Sci. 2001;42:626-633.
13. McKendrick AM, Vingrys AJ, Badcock DR, Heywood JT. Visual field losses in subjects with migraine headaches. Invest Ophthalmol Vis Sci. 2000;41:1239-1247.
14. McKendrick AM, Cioffi GA, Johnson CA. Short-wavelength sensitivity deficits in patients with migraine. Arch Ophthalmol. 2002;120:154-161.
15. McKendrick AM, Badcock DR. An analysis of the factors associated with visual field deficits measured with flickering stimuli in-between migraine. Cephalalgia. 2004;24:389-397.
16. McKendrick AM, Badcock DR. Decreased visual field sensitivity measured 1 day, then 1 week, after migraine. Invest Ophthalmol Vis Sci. 2004;45:1061-1070.
17. Venice O, Temel A, Incili B, Tuncer N. Short-wavelength automated perimetry in patients with migraine. Graefes Arch Clin Exp Ophthalmol. 2005;244:1-7.
18. Yucel I, Akar ME, Dora B, Akar Y, Taskin O, Ozer HO. Effect of the menstrual cycle on standard achromatic and blue-on-yellow visual field analysis of women with migraine. Can J Ophthalmol. 2005;40:51-57.
19. Harle DE, Evans BJ. Frequency doubling technology perimetry and standard automated perimetry in migraine. Ophthalmic Physiol Opt. 2005;25:233-239.
20. Shepherd AJ. Colour discrimination in migraineurs. In: Keyser A, MacGregor EA, eds. Headache and Migraine 7. Proceedings of the 7th Anglo-Dutch Migraine Association Meeting. 1999;23-35.
21. Shepherd A. Colour vision in migraine: selective deficits for S-cone discriminations. Cephalalgia. 2005;25:412-423.
22. Shepherd AJ. Color vision but not visual attention is altered in migraine. Headache. 2006;46:611-621.
23. Webster M. Human colour perception and its adaptation. Network: Computation in Neural Systems. 1996;7:587-634.
24. Landisman CE, Ts'o DY. Color processing in macaque striate cortex: electrophysiological properties. J Neurophysiol. 2002;87:3138-3151.
25. Mollon JD, Polden PG. An anomaly in the response of the eye to light of short wavelengths. Philos Trans R Soc Lond B Biol Sci. 1977;278:207-240.
26. Valeton JM, van Norren D. Transient tritanopia at the level of the ERG b-wave. Vision Res. 1979;19:689-693.
27. Valeton JM, Van Norren D. Retinal site of transient tritanopia. Nature. 1979;280:488-490.
28. Zrenner E, Gouras P. Characteristics of the blue sensitive cone mechanism in primate retinal ganglion cells. Vision Res. 1981;21:1605-1609.
29. Shepherd AJ. Increased visual after-effects following pattern adaptation in migraine: a lack of intracortical excitation? Brain. 2001;124:2310-2318.
30. Headache Classification Subcommittee of the International Headache Society. The international classification of headache disorders, 2nd ed. Cephalalgia. 2004;24(Suppl 1):24-36.
31. Reeves A. Transient tritanopia after flicker adaptation. Vision Res. 1981;21:657-664.
32. Reeves A. Transient tritanopia: its abolition at high intensities. Vision Res. 1981;21:665-672.
33. Smithson HE, Sumner P, Mollon JD. How to find a tritan line. Normal and Defective Colour Vision. 2003;279-287.
34. MacLeod DI, Boynton RM. Chromaticity diagram showing cone excitation by stimuli of equal luminance. J Opt Soc Am. 1979;69:1183-1186.
35. Brown LG. Additional rules for the transformed up-down method in psychophysics. Percept Psychophys. 1996;58:959-962.
36. Verriest G, Van Laethem J, Uvijls A. A new assessment of the normal ranges of the Farnsworth-Munsell 100-hue test scores. Am J Ophthalmol. 1982;93:635-642.
37. McLellan JS, Eskew RT. ON and OFF S-cone pathways have different long-wave cone inputs. Vision Res. 2000;40:2449-2465.
38. Vassilev A, Mihaylova MS, Racheva K, Zlatkova M, Anderson RS. Spatial summation of S-cone ON and OFF signals: effects of retinal eccentricity. Vision Res. 2003;43:2875-2884.
39. Vassilev A, Zlatkova M, Manahilov V, Krumov A, Schaumberger M. Spatial summation of blue-on-yellow light increments and decrements in human vision. Vision Res. 2000;40:989-1000.
40. Wang Q, Richters DP, Eskew RT. Interactions of S cone increments and decrements with L and M cone signals (Abstract). J Vision. 2003;3:449.
41. Shepherd AJ. A vector model of colour contrast in a cone-excitation colour space. Perception. 1997;26:455-470.
42. Shepherd AJ. Remodelling colour contrast: implications for visual processing and colour representation. Vision Res. 1999;39:1329-1345.
43. Tibber MS, Shepherd A. Evidence for precortical, potentially retinal-based abnormalities of the visual system in migraine (Abstract). Cephalalgia. 2005;25:1013.
44. McColl SL, Wilkinson F. Visual contrast gain control in migraine: measures of visual cortical excitability and inhibition. Cephalalgia. 2000;20:74-84.
45. Ditchfield JA, McKendrick AM, Badcock DR. Processing of global form and motion in migraineurs. Vision Res. 2006;46:141-148.
46. Augenstein EJ, Pugh EN Jr. The dynamics of the pi 1 colour mechanism: further evidence for two sites of adaptation. J Physiol. 1977;272:247-281.
47. Haug BA, Hermsteiner EM, Bandelow B, Paulus W. Parallel increase of heterochromatic increment threshold and postadaptation thresholds in Parkinson's disease and in neuroleptic treatment. Vision Res. 1997;37:3535-3547.
48. Steinhoff BJ, Freudenthaler N, Paulus W. The influence of established and new antiepileptic drugs on visual perception. 1. A placebo-controlled, double-blind, single-dose study in healthy volunteers. Epilepsy Res. 1997;29:35-47.
49. Steinhoff BJ, Freudenthaler N, Paulus W. The influence of established and new antiepileptic drugs on visual perception. II. A controlled study in patients with epilepsy under long-term antiepileptic medication. Epilepsy Res. 1997;29:49-58.
50. Martinez F, Castillo J, Rodriguez JR, Leira R, Noya M. Neuroexcitatory amino acid levels in plasma and cerebrospinal fluid during migraine attacks. Cephalalgia. 93;13:89-93.
51. Peres MF, Zukerman E, Senne Soares CA, Alonso EO, Santos BF, Faulhaber MH. Cerebrospinal fluid glutamate levels in chronic migraine. Cephalalgia. 2004;24:735-739.
52. Welch KM, D'Andrea G, Tepley N, Barkley G, Ramadan NM. The concept of migraine as a state of central neuronal hyperexcitability. Neurol Clin. 1990;8:817-828.
53. Welch KM, Chabi E, Bartosh K, Achar VS, Meyer JS. Cerebrospinal fluid gamma aminobutyric acid levels in migraine. BMJ. 1975;3:516-517.
54. Welch KM, Chabi E, Nell JH, et al. Biochemical comparison of migraine and stroke. Headache. 1976;16:160-167.
55. Kowa H, Shimomura T, Takahashi K. Platelet gamma-aminobutyric acid levels in migraine and tension-type headache. Headache. 1992;32:229-232.
56. Aurora SK, Cao Y, Bowyer SM, Welch KM. The occipital cortex is hyperexcitable in migraine: experimental evidence. Headache. 1999;39:469-476.
57. Palmer JE, Chronicle EP, Rolan P, Mulleners WM. Cortical hyperexcitability is cortical under-inhibition: evidence from a novel functional test of migraine patients. Cephalalgia. 2000;20:525-532.
58. Mulleners WM, Chronicle EP, Palmer JE, Koehler PJ, Vredeveld JW. Visual cortex excitability in migraine with and without aura, Headache. 2001;41:565-572.
59. Shepherd AJ, Palmer JE, Davis G. Increased visual after-effects in migraine following pattern adaptation extend to simultaneous tilt illusion. Spat Vis. 2002;16:33-43.
60. Shepherd A. Visual adaptation in migraine: local and global motion after-effects are pronounced and both exhibit storage (Abstract). Cephalalgia. 2005;25:1014.
61. Mollon JD. What is odd about the short-wavelength mechanism and why is it disproportionately vulnerable to acquired damage? Doc Ophthalmol Proc. 1982;33:145-149.
62. Hayashi M, Yamamoto S. Changes of cone electroretinograms to colour flash stimuli after successful retinal detachment surgery. Br J Ophthalmol. 2001;85:410-413.
63. Aldebasi YH, Drasdo N, Morgan JE, North RV. Cortical OFF-potentials from the S-cone pathway reveal neural damage in early glaucoma. Vision Res. 2003;43:221-226.
64. Calkins DJ. Seeing with S cones. Prog Retin Eye Res. 2001;20:255-287.
65. Shinomori K, Spillmann L, Werner JS. S-cone signals to temporal OFF-channels: asymmetrical connections to postreceptoral chromatic mechanisms. Vision Res. 1999;39:39-49.
66. Klug K, Herr S, Ngo IT, Sterling P, Schein S. Macaque retina contains an S-cone OFF midget pathway. J Neurosci. 2003;23:9881-9887.
67. Dacey DM, Lee BB. The 'blue-on' opponent pathway in primate retina originates from a distinct bistratified ganglion cell type. Nature. 1994;367:731-735.
68. Calkins DJ, Tsukamoto Y, Sterling P. Microcircuitry and mosaic of a blue-yellow ganglion cell in the primate retina. J Neurosci. 1998;18:3373-3385.